Clinuvel Pharmaceuticals Ltd (CLVLY)
8.95
+0.01
(+0.11%)
USD |
OTCM |
Nov 13, 15:59
Clinuvel Pharmaceuticals Price: 8.95 for Nov. 13, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2024 | 8.94 | 8.94 | 8.94 | 8.94 | 700.00 |
| Nov 11, 2024 | 8.885 | 8.94 | 8.82 | 8.94 | 6587.00 |
| Nov 08, 2024 | 9.02 | 9.02 | 8.90 | 8.937 | 1741.00 |
| Nov 07, 2024 | 9.205 | 9.260 | 9.205 | 9.205 | 4147.00 |
| Nov 06, 2024 | 8.85 | 9.01 | 8.85 | 8.976 | 1123.00 |
| Nov 05, 2024 | 8.942 | 9.06 | 8.942 | 8.975 | 4976.00 |
| Nov 04, 2024 | 9.04 | 9.175 | 9.00 | 9.175 | 950.00 |
| Nov 01, 2024 | 9.27 | 9.27 | 9.27 | 9.27 | 100.00 |
| Oct 31, 2024 | 9.531 | 9.531 | 9.531 | 9.531 | 0.000 |
| Oct 30, 2024 | 9.23 | 9.531 | 9.23 | 9.531 | 575.00 |
| Oct 29, 2024 | 9.35 | 9.35 | 9.35 | 9.35 | 0.000 |
| Oct 28, 2024 | 9.35 | 9.35 | 9.294 | 9.35 | 760.00 |
| Oct 25, 2024 | 9.315 | 9.315 | 9.315 | 9.315 | 112.00 |
| Oct 24, 2024 | 8.85 | 8.85 | 8.85 | 8.85 | 105.00 |
| Oct 23, 2024 | 9.03 | 9.79 | 9.03 | 9.37 | 3598.00 |
| Oct 22, 2024 | 9.35 | 9.35 | 9.35 | 9.35 | 0.000 |
| Oct 21, 2024 | 9.35 | 9.35 | 9.35 | 9.35 | 0.000 |
| Oct 18, 2024 | 9.45 | 9.56 | 9.35 | 9.35 | 7312.00 |
| Oct 17, 2024 | 9.97 | 9.97 | 9.45 | 9.45 | 1148.00 |
| Oct 16, 2024 | 9.75 | 9.75 | 9.75 | 9.75 | 0.000 |
| Oct 15, 2024 | 9.75 | 9.75 | 9.75 | 9.75 | 0.000 |
| Oct 14, 2024 | 9.75 | 9.75 | 9.75 | 9.75 | 501.00 |
| Oct 11, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 1146.00 |
| Oct 10, 2024 | 9.67 | 9.67 | 9.67 | 9.67 | 165.00 |
| Oct 09, 2024 | 9.35 | 9.35 | 9.35 | 9.35 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.10
Minimum
Mar 18 2020
31.29
Maximum
Sep 23 2021
14.94
Average
13.87
Median
Mar 14 2022
Price Benchmarks
| Alterity Therapeutics Ltd | 1.195 |
| Kazia Therapeutics Ltd | 5.59 |
| Immutep Ltd | 1.87 |
| Opthea Ltd | 3.74 |
| Mesoblast Ltd | 11.70 |
Price Related Metrics
| PE Ratio | 19.52 |
| PS Ratio | 7.896 |
| PEG Ratio | 0.3339 |
| Price to Book Value | 3.303 |
| Earnings Yield | 5.12% |
| Market Cap | 448.20M |
| PEGY Ratio | 0.3318 |
| Operating PE Ratio | 14.49 |
| Normalized PE Ratio | 19.52 |